Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review.
Karen Pesqueda-CendejasMelissa Rivera-EscotoMónica R Meza-MezaBertha Campos-LópezIsela Parra-RojasMargarita Montoya-BuelnaUlises de la Cruz-MossoPublished in: Nutrients (2023)
Systemic lupus erythematosus (SLE) is a chronic pathology characterized by a bimodal mortality pattern attributed to clinical disease activity and cardiovascular disease (CVD). A complex interaction between traditional CVD risk factors such as obesity, dyslipidemia, smoking, insulin resistance, metabolic syndrome, and hypertension, as well as the presence of non-traditional CVD risk factors such as hyperhomocysteinemia, pro-inflammatory cytokines, and C-reactive protein levels, has been suggested as a cause of the high prevalence of CVD in SLE patients. On the other hand, environmental factors, such as nutritional status, could influence the disease's prognosis; several nutrients have immunomodulators, antioxidants, and anti-cardiometabolic risk properties which could reduce SLE severity and organ damage by decreasing the development of traditional and non-traditional CVD risk factors. Therefore, this critical literature review discusses the therapeutic potential of nutritional approaches that could modulate the development of the main comorbidities related to CVD risk in SLE patients.
Keyphrases
- systemic lupus erythematosus
- disease activity
- risk factors
- cardiovascular disease
- metabolic syndrome
- insulin resistance
- rheumatoid arthritis
- end stage renal disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- ejection fraction
- type diabetes
- chronic kidney disease
- peritoneal dialysis
- juvenile idiopathic arthritis
- adipose tissue
- body mass index
- cardiovascular events
- oxidative stress
- weight loss
- patient reported outcomes
- physical activity
- risk assessment